✦ LIBER ✦

Phase II trial of the pan-deacetylase inhibitor panobinostat as a single agent in advanced relapsed/refractory multiple myeloma

✍ Scribed by Wolf, Jeffrey L.; Siegel, David; Goldschmidt, Hartmut; Hazell, Katharine; Bourquelot, Priscille M.; Bengoudifa, Bourras R.; Matous, Jeffrey; Vij, Ravi; de Magalhaes-Silverman, Margarida; Abonour, Rafat; Anderson, Kenneth C.; Lonial, Sagar

Book ID: 120658197
Publisher: Informa plc
Year: 2012
Tongue: English
Weight: 167 KB
Volume: 53
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2012.661175

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II multiple dose clinical trial

A phase II multiple dose clinical trial of histone deacetylase inhibitor ITF2357 in patients with relapsed or progressive multiple myeloma

✍ Monica Galli; Silvia Salmoiraghi; Joseé Golay; Antonella Gozzini; Claudia Crippa 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 105 KB

A Phase II Trial of Panobinostat, a Hist

A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma

✍ Hainsworth, John D.; Infante, Jeffrey R.; Spigel, David R.; Arrowsmith, Edward R 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 194 KB

Extended follow-up of a phase II trial i

Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma: : Final time-to-event results from the SUMMIT trial

✍ Paul G. Richardson; Bart Barlogie; James Berenson; Seema Singhal; Sundar Jaganna 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 2 views

Trabectedin as single agent in relapsed

Trabectedin as single agent in relapsed advanced ovarian cancer: results from a retrospective pooled analysis of three phase II trials

✍ Campo, JosÃ© MarÃa; Sessa, Cristiana; Krasner, Carolyn N.; Vermorken, Jan B.; C 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 348 KB

An Open-Label Single-Arm Pilot Phase II

An Open-Label Single-Arm Pilot Phase II Study (PX-171-003-A0) of Low-Dose, Single-Agent Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma

✍ Jagannath, Sundar; Vij, Ravi; Stewart, A. Keith; Trudel, Suzanne; Jakubowiak, An 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 400 KB

Thalidomide has limited single-agent act

Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B

✍ Sonali M. Smith; David Grinblatt; Jeffrey L. Johnson; Donna Niedzwiecki; David R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB